Multiple Myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
1740
|
865
|
0.030 |
None |
1.000 |
3 |
|
1993 |
2017 |
Hepatitis D Infection
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
72
|
4
|
0.010 |
None |
1.000 |
1 |
|
1994 |
1994 |
Hepatitis A
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
451
|
27
|
0.010 |
None |
1.000 |
1 |
|
1994 |
1994 |
Polycystic Kidney, Autosomal Dominant
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
280
|
35
|
0.030 |
None |
0.667 |
3 |
1
|
1998 |
1999 |
Polycystic kidney disease, type 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
15
|
41
|
0.020 |
None |
1.000 |
2 |
|
1998 |
2000 |
cystic disease
|
disease |
|
Disease or Syndrome
|
19
|
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Autosomal Recessive Polycystic Kidney Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
69
|
317
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Polycystic Kidney Diseases
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
276
|
54
|
0.030 |
None |
1.000 |
3 |
|
2002 |
2018 |
Antisocial Personality Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
63
|
6
|
0.100 |
None |
0.933 |
30 |
|
2007 |
2020 |
Anxiety Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
840
|
163
|
0.030 |
None |
0.667 |
3 |
|
2007 |
2019 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.030 |
None |
0.667 |
3 |
|
2007 |
2019 |
Taste sour
|
phenotype |
|
Sign or Symptom
|
4
|
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2019 |
Episodic Kinesigenic Dyskinesia 1
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
153
|
18
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
15 |
1
|
2011 |
2019 |
Violence
|
phenotype |
|
Mental or Behavioral Dysfunction
|
70
|
6
|
0.030 |
None |
0.667 |
3 |
|
2011 |
2018 |
Glucose measurement
|
phenotype |
|
Laboratory Procedure
|
89
|
111
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Antisocial behavior
|
phenotype |
Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
51
|
17
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Retinal Detachment
|
disease |
Eye Diseases
|
Disease or Syndrome
|
148
|
10
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
elevated blood glucose level
|
phenotype |
|
Finding
|
89
|
111
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Phospholipid measurement
|
phenotype |
|
Laboratory Procedure
|
58
|
306
|
0.100 |
None |
1.000 |
2 |
1
|
2012 |
2013 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2018 |
Fatty acid measurement
|
group |
|
Laboratory Procedure
|
50
|
116
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |